SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art

SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art

Abstract Identification of biomarkers in cancer immunotherapy that predict therapeutic response and/or limit adverse events are a critical need in the field. To address recent progress and hurdles around cancer biomarker development and utilization, the Society for Immunotherapy of Cancer (SITC) con...

Full description

Bibliographic Details
Main Authors: Lisa H. Butterfield, Mary L. Disis, Bernard A. Fox, David R. Kaufman, Samir N. Khleif, Ena Wang, on behalf of the Society for Immunotherapy of Cancer Immuno-Oncology Biomarkers: State of the Art workshop speakers
Format: Article
Language:English
Published: BMJ Publishing Group 2018-12-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Biomarkers
Cancer immunotherapy
PD-1/PD-L1
Checkpoint inhibitor
Online Access:http://link.springer.com/article/10.1186/s40425-018-0453-4

Internet

http://link.springer.com/article/10.1186/s40425-018-0453-4

Similar Items